Professor of Medicine
Princess Margaret Cancer Centre, Toronto, ON, Canada
Toronto, Ontario, Canada
• Dr Trudel has previously served as a member of the steering committee of the Multiple Myeloma Research Consortium (MMRC) and a member of the subcommittee on Plasma Cell Biology for the American Society of Hematology (ASH). She is currently a special expert member of the National Cancer Institute myeloma steering committee, a member of Myeloma Canada advisory board, and a member of the subcommittee on correlative sciences for the National Cancer Institute of Canada Clinical Trials Group
• Her research focus has been in the areas of novel drug development involving identification and validation of new therapeutic targets as well as development of novel platforms to support clinical trials of personalized medicine
• Dr Trudel has published over 150 peer-reviewed articles
Disclosure information not submitted.
Saturday, September 28, 2024
12:03 PM – 12:15 PM East Coast USA Time
Genetic and epigenetic markers for drug selection
Saturday, September 28, 2024
12:35 PM – 12:45 PM East Coast USA Time
Saturday, September 28, 2024
1:15 PM – 1:45 PM East Coast USA Time